LEADER 05744nam 2200661 450 001 9910786702203321 005 20231022150032.0 010 $a92-4-069066-2 035 $a(CKB)2670000000356458 035 $a(EBL)1179568 035 $a(OCoLC)843200358 035 $a(SSID)ssj0001065979 035 $a(PQKBManifestationID)12365184 035 $a(PQKBTitleCode)TC0001065979 035 $a(PQKBWorkID)11065738 035 $a(PQKB)10205271 035 $a(MiAaPQ)EBC1179568 035 $a(Au-PeEL)EBL1179568 035 $a(CaPaEBR)ebr10931296 035 $a(EXLCZ)992670000000356458 100 $a20131031h20132013 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aSustaining the drive to overcome the global impact of neglected tropical diseases $esecond WHO report on neglected tropical diseases 210 1$aGeneva, Switzerland :$cWorld Health Organization,$d[2013] 210 4$dİ2013 215 $a1 online resource (153 p.) 300 $a"Produced under the overall direction and supervision of Dr. Lorenzo Savioli (Director) and Dr. Denis Daumerie (Programme Manager), WHO Department of Control of Neglected Tropical Diseases"--Back of title page. 311 $a92-4-156454-7 320 $aIncludes bibliographical references. 327 $aCover; Contents; FOREWORD BY THE DIRECTOR-GENERAL OF THE WORLD HEALTH ORGANIZATION; SUMMARY; 1 THE GLOBAL PUBLIC-HEALTH AGENDA NOW EMBRACES NEGLECTED TROPICAL DISEASES; 1.1 Recent developments in prevention and control; 1.2 The roadmap and the London declaration; 1.3 Opportunities for public-health programmes; 1.4 Costs of expanding activities; 1.5 WHO and the roadmap's targets; REFERENCES; 2 REACHING THE ROADMAP'S TARGETS; 2.1 Practical definitions of eradication, elimination and control; 2.2 Obstacles and risks to achieving targets; 2.2.1 Conflicts and population displacement 327 $a2.2.2 Population growth 2.2.3 Vector control; 2.2.4 Resistance to medicines and pesticides; 2.2.5 Insufficient capacity for scaling up; 2.2.6 Expectations overtaking science; 2.2.7 Inadequate support for research; 2.2.8 Climate change; REFERENCES; 3 DISEASES; REFERENCES; WOMEN, CHILDREN AND NEGLECTED TROPICAL DISEASES; Biological consequences; Sociocultural consequences; Stigma; REFERENCES; 3.1 Dengue; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.2 Rabies; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES 327 $a3.3 Trachoma Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.4 Buruli ulcer; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.5 Endemic treponematoses; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.6 Leprosy; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.7 Chagas disease; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.8 Human African trypanosomiasis (sleeping sickness) 327 $aIntroduction Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.9 Leishmaniases; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.10 Taeniasis/cysticercosis; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.11 Dracunculiasis (guinea-worm disease); Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.12 Echinococcosis; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.13 Foodborne trematodiases 327 $aIntroduction Distribution; Strategy (roadmap targets and milestones); REFERENCES; 3.14 Lymphatic filariasis; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.15 Onchocerciasis (river blindness); Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.16 Schistosomiasis; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES; 3.17 Soil-transmitted helminthiases; Introduction; Distribution; Impact; Strategy (roadmap targets and milestones); REFERENCES 327 $a4 KEY INTERVENTIONS: SITUATION REPORT 330 $aThe second WHO report on neglected tropical diseases builds on the growing sense of optimism generated by the 2012 publication of the WHO Roadmap. Commitments on the part of ministries of health in endemic countries global health initiatives funding agencies and philanthropists have escalated since 2010 as have donations of medicines from pharmaceutical companies and the engagement of the scientific community. This report marks a new phase and assesses opportunities and obstacles in the control elimination and eradication of several of these diseases. Unprecedented progress over the past two years ha 606 $aTropical medicine 606 $aCommunicable diseases$xPrevention 606 $aParasitic diseases 607 $aDeveloping countries 615 0$aTropical medicine. 615 0$aCommunicable diseases$xPrevention. 615 0$aParasitic diseases. 676 $a615.19 702 $aSavioli$b Lorenzo 702 $aDaumerie$b Denis 712 02$aWorld Health Organization.$bDepartment of Control of Neglected Tropical Diseases, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910786702203321 996 $aSustaining the drive to overcome the global impact of neglected tropical diseases$93826664 997 $aUNINA